Federal (United States) · Regulations
Subpart A
3 sections
3 sections
- 21 C.F.R. § 310.3Definitions and interpretations.
- 21 C.F.R. § 310.4Biologics; products subject to license control.
- 21 C.F.R. § 310.6Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.